Popular searches: AAPL TSLA NVDA MSFT GOOGL

CDTX Stock Price Prediction 2026

Cidara Therapeutics, Inc.

$221.38
+$0.06 (+0.03%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: January 6, 2026
🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • • Price consolidating in 0.44% range for 11 days
  • • MACD converging near zero line - potential energy building
  • • Volume showing accumulation (CMF: 0.1436)
  • • Price near support at $220.41
MACD: Bearish | Volume: Accumulation
Fair Value Estimate
0.0% Overvalued
Fair Value: $221.38 (Current: $221.38)

Based on PEG ratio analysis, this stock appears overvalued at current levels. Consider waiting for a better entry point or reassess fundamentals.

PEG Ratio
106.09
Expensive
Current P/E
5.75
Fair P/E
5.75
Earnings Growth
0.1%
📈

Volume Trend: Accumulation

Institutional Buying Detected - Smart money is accumulating shares

Chaikin Money Flow (CMF): 0.144
Money Flow Index (MFI): 79.4

Positive CMF indicates money flowing into the stock. This bullish signal suggests institutional interest.

Options Analysis: 1-Year Target Strategy

Score: 21/100

Analysis comparing options pricing vs AI growth projections. This helps identify if options are cheap (buy calls) or expensive (sell premium).

STRONG SELL SIGNAL - Massively overpriced, excellent premium selling opportunity
Wall Street Target
$221.50
+0.1% upside
Best Strike Found
$230.00
Exp: Jan. 15, 2027, midnight
Call Premium
$0.05
0.0% of stock price
Breakeven Price
$230.05
⚠ Above target
Implied Probability
13.3%
Market's confidence
Value Score
-100.0
Overpriced
💰
STRONG SELL
Options are overpriced - Sell premium opportunity
Seller's Advantage:
Premium Collected
$0.05
Profit if Target Hits
$0.05
ROI if Target Hits
+100.0%
Why This Works: Buyers lose 100.0% even if target hits. Premium is overpriced for 0.1% move.
Suggested Strategies: Covered Call (safest) Naked Call (risky) Credit Spread (defined risk)
Open Interest: 156 | Volume: 20
Data as of: Jan 30, 2026
How to Use This Analysis: Value Score shows profitability if the 1-year growth target is reached. Positive score = profitable for buyers. Negative score = profit opportunity for premium sellers (covered calls, credit spreads).
Price Targets by Timeframe
Based on Wall Street analyst consensus targets
Timeframe Target Price Potential Return
30 Days $221.39 +0.0%
90 Days $221.41 +0.0%
6 Months $221.44 +0.0%
1 Year $221.50 +0.1%

More CDTX Analysis

Why is CDTX Moving? Buy or Sell CDTX? CDTX Full Analysis CDTX Trendline Analysis
CDTX Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$276.88 (+25.1%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$221.50 (+0.1%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$155.05 (-30.0%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
84.6
Overbought
MACD Signal
Bearish
Trend
Uptrend
Money Flow (CMF)
0.14

Key Fundamentals

Forward P/E
5.75
Revenue Growth (QoQ)
-1.0%
Market Cap
$6,960M
Analyst Target
$221.50
52-Week High
$221.39
52-Week Low
$221.25

Options Activity

Alert Score
71/100
Classification
Moderate Alert
Unusual Activity
66.7

Recommendation: Moderate unusual activity. Monitor closely.

Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis